WASHINGTON (Reuters) – A bipartisan group of U.S. senators re-introduced a bill on Tuesday aimed at helping generic drug companies bring out a cheaper version of pharmaceuticals.
Makers of branded drugs have long been accused of refusing to provide samples of drugs on a government list of restricted medicines. Without the samples, generic competitors cannot prove their medicines are as safe and effective as the more expensive versions.
Senators - Chuck - Grassley - Mike - Lee
To combat this, Republican Senators Chuck Grassley and Mike Lee and Democrat Amy Klobuchar and...